Voyager Therapeutics, Inc.
VYGR
$3.47
-$0.06-1.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 266.68M | 345.36M | 371.02M | 399.57M | 230.88M |
| Total Receivables | 4.49M | 19.67M | 3.25M | 3.46M | 84.46M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 428.00K | 8.42M | 7.30M | 6.11M | 607.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.21M | -- | -- | -- | 3.75M |
| Total Current Assets | 276.81M | 373.44M | 381.57M | 409.14M | 319.68M |
|
|
|||||
| Total Current Assets | 276.81M | 373.44M | 381.57M | 409.14M | 319.68M |
| Net Property, Plant & Equipment | 47.66M | 49.72M | 51.78M | 56.59M | 30.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.87M | 2.87M | 2.87M | 2.89M | 1.59M |
| Total Assets | 393.05M | 426.04M | 436.23M | 469.59M | 351.28M |
|
|
|||||
| Total Accounts Payable | 4.00M | 3.16M | 2.61M | 7.58M | 1.60M |
| Total Accrued Expenses | 14.17M | 11.44M | 10.27M | 7.60M | 16.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.23M | 6.98M | 6.74M | 5.94M | 3.20M |
| Total Finance Division Other Current Liabilities | 24.39M | 22.63M | 20.52M | 51.44M | 42.88M |
| Total Other Current Liabilities | 24.39M | 22.63M | 20.52M | 51.44M | 42.88M |
| Total Current Liabilities | 49.79M | 44.21M | 40.13M | 72.55M | 64.51M |
|
|
|||||
| Total Current Liabilities | 49.79M | 44.21M | 40.13M | 72.55M | 64.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 36.50M | 38.37M | 40.21M | 42.00M | 17.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.00M | 13.15M | 20.47M | 14.16M | 33.36M |
| Total Liabilities | 93.29M | 95.73M | 100.81M | 128.71M | 114.96M |
|
|
|||||
| Common Stock & APIC | 626.35M | 622.04M | 618.59M | 613.90M | 497.55M |
| Retained Earnings | -326.18M | -291.70M | -282.65M | -272.51M | -261.18M |
| Treasury Stock & Other | -407.00K | -33.00K | -522.00K | -506.00K | -48.00K |
| Total Common Equity | 299.76M | 330.31M | 335.42M | 340.89M | 236.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 299.76M | 330.31M | 335.42M | 340.89M | 236.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 299.76M | 330.31M | 335.42M | 340.89M | 236.32M |
|
|
|||||